Macrogenics Inc (MGNX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Macrogenics Inc-Aktie (MGNX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	15.07% 9.104	10.72	10.40	13.14	24.50
Cost Of Revenue	65.64% 0.27	0.163	0.085	0.258	0.113
Gross Profit	16.32% 8.834	10.56	10.31	12.88	24.38
Operating Expenses	4.46% 62.58	59.91	45.81	57.84	62.81
Interest Income/Expense	1.133	-	-	0.774	0.656
Benefits Costs and Expenses	4.63% 62.85	60.07	45.90	58.10	62.92
Costs And Expenses	4.63% 62.85	60.07	45.90	58.10	62.92
Operating Income/Loss	8.91% -53.75	-49.35	-35.50	-44.96	-38.43
Income/Loss From Continuing Operations Before Tax	8.91% -53.75	-49.35	-35.50	57.47	-38.01
Income/Loss From Continuing Operations After Tax	13.28% -52.19	-46.07	17.55	57.47	-38.01
Net Income/Loss	13.28% -52.19	-46.07	17.55	57.47	-38.01
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	162.22K% 62.29	0.0384	61.98	61.88	61.81
Diluted Average Shares	38,755% 62.29	-0.1611	62.24	62.26	61.81
Basic Earnings Per Share	12.00% -0.84	-0.75	0.28	0.93	-0.61
Diluted Earnings Per Share	12.00% -0.84	-0.75	0.28	0.92	-0.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$77.28

2.02%

SMMT

$20.39

2.15%

UTHR

$382.77

1.58%

MRNA

$53.29

0.47%

BGNE

$208.03

0.38%

BNTX

$110.97

1.84%